Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding DisputeThe ongoing demand for GLP-1s has resulted in a significant shortage and legal dispute regarding alternative compounding pharmacies.
Excited about new diet drug? This procedure seems better deal. - Harvard GazetteMinimally invasive endoscopic bariatric procedure more cost-effective and brings more weight loss than new weight-loss medications.
Weight-loss drugs could become a test case for AIThe convergence of artificial intelligence and weight-loss drugs in healthcare is becoming increasingly prevalent for personalized care and improved patient outcomes.
The Promise of Weight-Loss DrugsOzempic is becoming synonymous with weight loss despite being a diabetes drug, but researchers believe it may revolutionize many fields of medicine beyond weight loss.